HEADER BIOSYNTHETIC PROTEIN/ANTIBIOTIC 06-OCT-22 8EPY TITLE THE SOLUTION STRUCTURE OF ABXF IN COMPLEX WITH ITS PRODUCT (-)-ABX, AN TITLE 2 ENZYME CATALYZING THE FORMATION OF THE CHIRAL SPIROKETAL OF AN TITLE 3 ANTHRABENZOXOCINONE ANTIBIOTIC, (-)-ABX COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYOXALASE; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOMYCES SP.; SOURCE 3 ORGANISM_TAXID: 1931; SOURCE 4 GENE: ABXF; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS CYANA 3.98.13, ENZYME, CATALYSIS, CHIRAL SPIROKETAL, BIOSYNTHETIC KEYWDS 2 PROTEIN-ANTIBIOTIC COMPLEX EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR X.JIA,X.YAN,X.QU,M.MOBLI REVDAT 2 15-MAY-24 8EPY 1 REMARK REVDAT 1 10-APR-24 8EPY 0 JRNL AUTH X.JIA,X.YAN,M.MOBLI,X.QU JRNL TITL THE SOLUTION STRUCTURE OF ABXF, AN ENZYME CATALYZING THE JRNL TITL 2 FORMATION OF CHIRAL SPIROKETAL OF AN ANTIBIOTICS, (-)-ABX. JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA REMARK 3 AUTHORS : GUNTERT, MUMENTHALER AND WUTHRICH REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8EPY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-OCT-22. REMARK 100 THE DEPOSITION ID IS D_1000269112. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.6 REMARK 210 IONIC STRENGTH : 20 MM SODIUM PHOSPHATE AND 50 MM REMARK 210 NACL REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 1.25 MM [U-100% 13C; U-100% 15N] REMARK 210 ABXF, 1.25 MM (-)-ABX, 5 % V/V REMARK 210 [U-100% 2H] D2O, 95 % V/V H2O, REMARK 210 50 MM SODIUM CHLORIDE, 20 MM REMARK 210 SODIUM PHOSPHATE, 3 MM SODIUM REMARK 210 AZIDE, 5 MM DTT, 95% H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC; REMARK 210 2D 1H-13C HSQC AROMATIC; 2D 1H- REMARK 210 1H NOESY - FILTERED; 2D 1H-13C REMARK 210 HSQC CONSTANT TIME; 3D 1H-13C REMARK 210 NOESY ALIPHATIC; 3D 1H-13C NOESY REMARK 210 ALIPHATIC - FILTERED; 3D 1H-13C REMARK 210 NOESY AROMATIC; 3D 1H-13C NOESY REMARK 210 AROMATIC - FILTERED; 3D 1H-15N REMARK 210 NOESY; 3D 1H-15N NOESY - REMARK 210 FILTERED; 3D HNCA; 3D HCCH-TOCSY; REMARK 210 3D CBCA(CO)NH; 3D HNCACB; 3D REMARK 210 HN(CA)CO; 3D HNCO REMARK 210 SPECTROMETER FIELD STRENGTH : 900 MHZ; 700 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CYANA, CCPNMR ANALYSIS VERSION REMARK 210 2.4.2 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 THR A 14 -71.75 -82.82 REMARK 500 1 VAL A 58 -69.48 -125.43 REMARK 500 1 PRO A 70 -167.10 -69.83 REMARK 500 1 TRP A 75 157.68 -49.28 REMARK 500 1 ASP A 83 147.04 -176.04 REMARK 500 1 THR A 131 31.70 -97.15 REMARK 500 1 ASP A 137 34.50 -95.38 REMARK 500 1 ARG A 144 -169.40 -179.08 REMARK 500 1 ALA A 151 67.54 -153.03 REMARK 500 1 THR A 173 45.22 -100.75 REMARK 500 1 ALA A 189 151.93 177.34 REMARK 500 1 TYR A 194 110.58 -160.01 REMARK 500 1 TYR A 218 179.27 179.43 REMARK 500 2 HIS A 3 107.08 -174.82 REMARK 500 2 THR A 14 -75.92 -84.29 REMARK 500 2 ASP A 63 -167.92 -119.45 REMARK 500 2 PRO A 70 -175.68 -69.76 REMARK 500 2 SER A 76 147.25 -174.04 REMARK 500 2 LYS A 128 -33.59 -132.33 REMARK 500 2 THR A 131 31.72 -95.90 REMARK 500 2 SER A 133 102.32 -54.44 REMARK 500 2 ALA A 151 70.09 -179.83 REMARK 500 2 ALA A 189 151.44 178.01 REMARK 500 2 ASP A 219 64.29 66.79 REMARK 500 3 THR A 14 -75.58 -77.03 REMARK 500 3 ASP A 63 -168.17 -129.90 REMARK 500 3 PRO A 70 -173.24 -69.76 REMARK 500 3 SER A 76 145.45 -173.19 REMARK 500 3 ASP A 83 146.94 -173.30 REMARK 500 3 ALA A 151 69.41 -179.68 REMARK 500 3 ALA A 189 151.03 177.96 REMARK 500 3 TYR A 218 -179.33 179.45 REMARK 500 3 ASP A 219 64.85 66.55 REMARK 500 4 THR A 14 -71.24 -85.48 REMARK 500 4 VAL A 58 -70.07 -125.41 REMARK 500 4 PRO A 70 -169.84 -69.72 REMARK 500 4 ASP A 137 32.46 -95.84 REMARK 500 4 ARG A 144 -168.29 -164.22 REMARK 500 4 ALA A 151 70.32 -179.10 REMARK 500 4 THR A 173 41.91 -144.61 REMARK 500 4 ALA A 181 137.32 -172.07 REMARK 500 4 ALA A 189 150.35 177.55 REMARK 500 4 TYR A 218 179.29 179.11 REMARK 500 5 THR A 14 -75.92 -91.02 REMARK 500 5 SER A 46 108.02 -49.53 REMARK 500 5 VAL A 58 -53.64 -125.44 REMARK 500 5 ASP A 63 -169.60 -121.65 REMARK 500 5 PRO A 70 -172.26 -69.75 REMARK 500 5 LYS A 128 -33.44 -132.51 REMARK 500 5 THR A 131 31.47 -95.41 REMARK 500 REMARK 500 THIS ENTRY HAS 269 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 31046 RELATED DB: BMRB REMARK 900 THE SOLUTION STRUCTURE OF ABXF IN COMPLEX WITH ITS PRODUCT (-)-ABX, REMARK 900 AN ENZYME CATALYZING THE FORMATION OF THE CHIRAL SPIROKETAL OF AN REMARK 900 ANTHRABENZOXOCINONE ANTIBIOTIC, (-)-ABX DBREF1 8EPY A 1 242 UNP A0A2I6B3F9_STRSQ DBREF2 8EPY A A0A2I6B3F9 1 242 SEQADV 8EPY GLY A -2 UNP A0A2I6B3F EXPRESSION TAG SEQADV 8EPY SER A -1 UNP A0A2I6B3F EXPRESSION TAG SEQADV 8EPY HIS A 0 UNP A0A2I6B3F EXPRESSION TAG SEQRES 1 A 245 GLY SER HIS MET SER HIS ASP ALA VAL ARG PRO ALA PRO SEQRES 2 A 245 GLY GLU PRO THR TRP VAL ASP LEU LEU THR PRO ASP ARG SEQRES 3 A 245 GLY ALA ALA LEU GLN PHE TYR SER ALA LEU PHE GLY TRP SEQRES 4 A 245 GLU PHE SER THR THR SER ASP GLY THR SER PRO TYR THR SEQRES 5 A 245 MET CYS ARG LEU ARG GLY ARG GLU VAL CYS SER ILE GLY SEQRES 6 A 245 ASP LEU GLY GLU ASN PRO GLY PRO ALA LEU GLY GLY TRP SEQRES 7 A 245 SER SER TYR LEU SER VAL ASP ASP ALA ASP ALA ALA ALA SEQRES 8 A 245 ALA ALA VAL PRO GLU LEU GLY GLY ALA VAL LEU LEU GLY SEQRES 9 A 245 PRO ILE ASP ILE LEU ALA GLN GLY ARG MET LEU LEU ALA SEQRES 10 A 245 GLY ASP PRO SER GLY HIS ARG VAL GLY LEU TRP GLN ALA SEQRES 11 A 245 LYS GLU HIS THR GLY SER GLY PRO ASP ASP GLY ILE GLY SEQRES 12 A 245 ALA TYR THR ARG SER GLU LEU LEU THR GLY ALA SER ALA SEQRES 13 A 245 THR ASP GLY ALA PHE TYR ARG GLY LEU PHE GLY ALA ASP SEQRES 14 A 245 PHE ALA THR GLU SER GLY THR ASP GLY GLY GLY ARG ARG SEQRES 15 A 245 ALA ALA ILE ARG GLN VAL GLY PRO ALA ALA PRO SER GLY SEQRES 16 A 245 TRP TYR PRO CYS PHE ARG ALA GLN GLU SER ALA VAL PRO SEQRES 17 A 245 ALA ALA VAL MET LEU GLY ALA SER VAL LEU LEU ARG TYR SEQRES 18 A 245 ASP CYS PRO ASP GLY PRO ALA VAL VAL VAL SER ALA PRO SEQRES 19 A 245 GLY GLY GLU VAL PHE THR LEU LEU LEU THR ASP HET WOZ A 301 58 HETNAM WOZ (6R,16R)-3,11,13,15-TETRAHYDROXY-1,6,9,9-TETRAMETHYL-6, HETNAM 2 WOZ 7,9,16-TETRAHYDRO-14H-6,16-EPOXYANTHRA[2,3- HETNAM 3 WOZ E]BENZO[B]OXOCIN-14-ONE FORMUL 2 WOZ C27 H24 O7 HELIX 1 AA1 ASP A 22 GLY A 35 1 14 HELIX 2 AA2 ASP A 83 GLY A 95 1 13 HELIX 3 AA3 ALA A 151 PHE A 163 1 13 HELIX 4 AA4 GLY A 164 ALA A 168 5 5 HELIX 5 AA5 SER A 202 MET A 209 1 8 SHEET 1 AA1 3 ASP A 17 LEU A 18 0 SHEET 2 AA1 3 ARG A 56 ILE A 61 1 O SER A 60 N LEU A 18 SHEET 3 AA1 3 MET A 50 LEU A 53 -1 N LEU A 53 O ARG A 56 SHEET 1 AA2 3 TYR A 78 VAL A 81 0 SHEET 2 AA2 3 GLY A 123 GLN A 126 1 O GLY A 123 N LEU A 79 SHEET 3 AA2 3 MET A 111 LEU A 112 -1 N LEU A 112 O LEU A 124 SHEET 1 AA3 5 TYR A 142 ARG A 144 0 SHEET 2 AA3 5 CYS A 196 ARG A 198 -1 O CYS A 196 N THR A 143 SHEET 3 AA3 5 VAL A 235 LEU A 239 1 O LEU A 239 N PHE A 197 SHEET 4 AA3 5 ALA A 225 SER A 229 -1 N VAL A 226 O LEU A 238 SHEET 5 AA3 5 SER A 213 LEU A 216 -1 N SER A 213 O SER A 229 SHEET 1 AA4 3 ILE A 182 GLN A 184 0 SHEET 2 AA4 3 LEU A 147 THR A 149 1 N LEU A 147 O ARG A 183 SHEET 3 AA4 3 GLY A 192 TRP A 193 -1 O GLY A 192 N LEU A 148 CISPEP 1 GLY A 101 PRO A 102 1 0.08 CISPEP 2 GLY A 101 PRO A 102 2 0.06 CISPEP 3 GLY A 101 PRO A 102 3 0.06 CISPEP 4 GLY A 101 PRO A 102 4 0.09 CISPEP 5 GLY A 101 PRO A 102 5 0.04 CISPEP 6 GLY A 101 PRO A 102 6 0.00 CISPEP 7 GLY A 101 PRO A 102 7 0.10 CISPEP 8 GLY A 101 PRO A 102 8 0.13 CISPEP 9 GLY A 101 PRO A 102 9 0.05 CISPEP 10 GLY A 101 PRO A 102 10 0.06 CISPEP 11 GLY A 101 PRO A 102 11 0.06 CISPEP 12 GLY A 101 PRO A 102 12 0.07 CISPEP 13 GLY A 101 PRO A 102 13 0.08 CISPEP 14 GLY A 101 PRO A 102 14 0.09 CISPEP 15 GLY A 101 PRO A 102 15 0.08 CISPEP 16 GLY A 101 PRO A 102 16 0.09 CISPEP 17 GLY A 101 PRO A 102 17 0.08 CISPEP 18 GLY A 101 PRO A 102 18 0.04 CISPEP 19 GLY A 101 PRO A 102 19 0.09 CISPEP 20 GLY A 101 PRO A 102 20 -0.03 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1